Department of Neurology, Neuroscience Faculty Center, National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, 560029, India.
Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, Canada.
Neurogenetics. 2024 Oct;25(4):435-469. doi: 10.1007/s10048-024-00776-6. Epub 2024 Aug 5.
Congenital Muscular Dystrophies (CMD) are phenotypically and genotypically heterogenous disorders with a prevalence of 0.68 to 2.5/100,000, contributing to significant morbidity and mortality. We aimed to study the phenotype-genotype spectrum of genetically confirmed cases of CMD. This was retrospective & descriptive study done at a quaternary care referral centre in south India. Genetically confirmed cases of CMDs seen between 2010 to 2020 were recruited. Detailed clinical history, including pedigree, MRI brain/muscle, next generation sequencing results of 61 CMD cases were collected. Collagen VI-related dystrophy (COL6-RD) (36%) was the most common subtype with variants frequently seen in COL6A1 gene. Other CMDs identified were LAMA2-RD (26%), alpha-dystroglycan-RD (19%), LMNA-RD (8%), CHKB-RD (7%) and SEPN1-RD (3%). Similar to previous cohorts, overall, missense variants were common in COL-6 RD. Variants in triple helical domain (THD) of COL6-RD were seen in 11/22 patients, 5 of whom were ambulatory contrary to previous literature citing severe disease with these variants. However, our follow-up period was shorter. In the LAMA2-RD, 2/16 patients were ambulatory & all 16 carried truncating variants. Among dystroglycanopathies, FKRP-RD was the commonest. Milder phenotype of FKRP- RD was observed with variant c.1343C > T, which was also a recurrent variant in our cohort. p.Arg249Trp variant in LMNA-CMD associated with early loss of ambulation was also identified in 1/5 of our patients who expired at age 2.8 years. The current retrospective series provides detailed clinical features and mutation patterns of genetically confirmed cases of CMD from a single center in India.
先天性肌肉营养不良症(CMD)是一种表型和基因型异质性疾病,患病率为 0.68 至 2.5/100,000,导致发病率和死亡率显著升高。我们旨在研究经基因证实的 CMD 病例的表型-基因型谱。这是在印度南部的一家四级保健转诊中心进行的回顾性和描述性研究。我们招募了 2010 年至 2020 年间确诊的 CMD 基因病例。收集了 61 例 CMD 病例的详细临床病史,包括家族史、大脑/肌肉 MRI、下一代测序结果。COL6-RD(36%)是最常见的亚型,常见于 COL6A1 基因中的变体。确定的其他 CMD 包括 LAMA2-RD(26%)、alpha- 肌营养不良蛋白-RD(19%)、LMNA-RD(8%)、CHKB-RD(7%)和 SEPN1-RD(3%)。与之前的队列类似,总体而言,COL-6 RD 中常见错义变体。在 COL6-RD 的三螺旋结构域(THD)中观察到 11/22 例患者的变体,其中 5 例患者能够行走,与之前文献中提到的这些变体导致严重疾病的观点相反。然而,我们的随访期较短。在 LAMA2-RD 中,16 例中有 2 例患者能够行走,且所有患者均携带截断变体。在 dystroglycanopathies 中,FKRP-RD 是最常见的。在我们的队列中,FKRP-RD 的 c.1343C > T 变体也是一种常见的变体,观察到该变体的表型较轻。LMNA-CMD 中的 p.Arg249Trp 变体也与 1/5 例在 2.8 岁时丧失行走能力并死亡的患者相关。本回顾性研究提供了来自印度单一中心的经基因证实的 CMD 病例的详细临床特征和突变模式。